Abstract:Among the most lethal forms of cancer, malignant brain tumors persist as one of the greatest challenges faced by oncologists, where nanotechnology-driven theranostics can play a critical role in developing novel polymer-based supramolecular nanoarchitectures with multifunctional and multi-modal characteristics to fight cancer. However, it is virtually a consensus that, besides the complexity of active delivering anticancer drugs by the nanocarriers to the tumor site, the current evaluation methods primarily relying on in vitro assays and in vivo animal models have been accounted for the low translational effectiveness to clinical applications. In this view, the chick chorioallantoic membrane (CAM) assay has been increasingly recognized as one of the best preclinical models to study the effects of anticancer drugs on the tumor microenvironment (TME). Thus, in this study, we designed, characterized, and developed novel hybrid nanostructures encompassing chemically functionalized carboxymethylcellulose (CMC) with mitochondria-targeting pro-apoptotic peptide (KLA) and cell-penetrating moiety (cysteine, CYS) with fluorescent inorganic semiconductor (Ag-In-S, AIS) for simultaneously bioimaging and inducing glioblastoma cancer cell (U-87 MG, GBM) death. The results demonstrated that the CMC-peptide macromolecules produced supramolecular vesicle-like nanostructures with aqueous colloidal stability suitable as nanocarriers for passive and active targeting of cancer tumors. The optical properties and physicochemical features of the nanoconjugates confirmed their suitability as photoluminescent nanoprobes for cell bioimaging and intracellular tracking. Moreover, the results in vitro demonstrated a notable killing activity towards GBM cells of cysteine-bearing CMC conjugates coupled with pro-apoptotic KLA peptides. More importantly, compared to doxorubicin (DOX), a model anticancer drug in chemotherapy that is highly toxic, these innovative nanohybrids nanoconjugates displayed higher lethality against U-87 MG cancer cells. In vivo CAM assays validated these findings where the nanohybrids demonstrated a significant reduction of GBM tumor progression (41% area) and evidenced an antiangiogenic activity. These results pave the way for developing polymer-based hybrid nanoarchitectonics applied as targeted multifunctional theranostics for simultaneous imaging and therapy against glioblastoma while possibly reducing the systemic toxicity and side-effects of conventional anticancer chemotherapeutic agents.

Multifunctionalized Carbon Dots as an Active Nanocarrier for Drug Delivery to the Glioblastoma Cell Line

Preparation of a Multifunctional Nano-carrier System Based on Carbon Dots with Ph-Triggered Drug Release

Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model

Augmented Glioma-Targeted Theranostics Using Multifunctional Polymer-Coated Carbon Nanodots.

Glioma and Microenvironment Dual Targeted Nanocarrier for Improved Antiglioblastoma Efficacy

Multistage Nanocarrier Based on an Oil Core–Graphene Oxide Shell

Carboxymethylcellulose biofunctionalized ternary quantum dots for subcellular-targeted brain cancer nanotheranostics

Multimodal targeting of glioma with functionalized nanoparticles

Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.

A Smart Drug-Delivery Nanosystem Based on Carboxylated Graphene Quantum Dots for Tumor-Targeted Chemotherapy.

Development of a Hybrid Nanocarrier-Recognizing Tumor Vasculature and Penetrating the BBB for Glioblastoma Multi-Targeting Therapy.

Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells

Ddel-09. As1411 Aptamer-Conjugated Nanospheres For Targeting Glioblastoma Therapy

Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells

Nanoparticles of 2-Deoxy-d-glucose Functionalized Poly(ethylene Glycol)-Co-poly(trimethylene Carbonate) for Dual-Targeted Drug Delivery in Glioma Treatment

Targeted therapy for the treatment of gliomas with multifunctional orange emissive carbon dots

Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy

Recent Strategies of Carbon Dots Based Nanodrugs for Enhanced Emerging Antitumor Modalities

CARBON DOTS: Bioimaging and Anticancer Drug Delivery

High Throughput Screening of Surface Engineered Cyanine Nanodots for Active Transport of Therapeutic Antibody into Solid Tumor

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model